Sanlao, Rudolf B.
HRN: 24-69-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/13/2024
03/20/2024
IV
2.25g
Q6
Septic Shock Sec To CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes